Evidence map›Paper›PMID 28430166›Full record

ArticleViruses2017

"French Phage Network"-Second Meeting Report.

Clara Torres-Barceló, Oliver Kaltz, Rémy Froissart, Sylvain Gandon, Nicolas Ginet, Mireille Ansaldi

Open access · goldAbstract readConference Proceedings
In one paragraph

Article in Viruses, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Viruses of Microbes.Viruses · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Clara Torres-BarcelóPlant Populations and Bio-aggressors in Tropical Ecosystems (PVBMT) UMR, Pôle de Protection des Plantes, F-97410, Saint-Pierre, Reunion Island, France. clara.torres@univ-montp2.fr.
Oliver KaltzInstitut des Sciences de l'Evolution, UMR 5554 (CC065), Université de Montpellier, F-34095 Montpellier, France. oliver.kaltz@univ-montp2.fr.
Rémy FroissartCNRS, IRD, Université de Montpellier, Laboratory «Maladies Infectieuses & Vecteurs : Ecologie, Génétique, Evolution & Contrôle» (MIVEGEC), UMR 5290, F-34394 Montpellier, France. remy.froissart@cnrs.fr.
Sylvain GandonCNRS, Université de Montpellier, Centre d'Ecologie Fonctionnelle et Evolutive (CEFE), UMR 5175, F-34293 Montpellier, France. sylvain.gandon@cefe.cnrs.fr.
Nicolas GinetCNRS, Aix-Marseille Université, Laboratoire de chimie bactérienne, UMR 7283, Institut de Microbiologie de la Méditerranée, F-13402 Marseille, France. nginet@imm.cnrs.fr.
Mireille AnsaldiCNRS, Aix-Marseille Université, Laboratoire de chimie bactérienne, UMR 7283, Institut de Microbiologie de la Méditerranée, F-13402 Marseille, France. ansaldi@imm.cnrs.fr.
Centre National de la Recherche Scientifique · FRPeuplements végétaux et bioagresseurs en milieu tropical · REUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study of bacteriophages (viruses of bacteria) includes a variety of approaches, such as structural biology, genetics, ecology, and evolution, with increasingly important implications for therapeutic and industrial uses. Researchers working with phages in France have recently established a network to facilitate the exchange on complementary approaches, but also to engage new collaborations. Here, we provide a summary of the topics presented during the second meeting of the French Phage Network that took place in Marseille in November 2016.

Indexed as

Community NetworksBacteriophagesBiomedical ResearchFranceIntersectoral Collaborationbacteriaco-evolutionFrancegenomicsinfectionphagephage therapyresistancestructural biologyvirulence

Identifiers

PMID28430166
PMCPMC5408693
OpenAlexW2605945040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.